fbpx
Unraveling the Mysteries of Cancer: The Revolutionary Breakthroughs You Need to Know Now

Unraveling the Mysteries of Cancer: The Revolutionary Breakthroughs You Need to Know Now

Five trailblazing companies – Genentech, Novartis, Bristol Myers Squibb, Moderna, and Curis – are leading the fight against cancer, collectively contributing $193 billion to cancer research in 2022. Genentech is moving away from generic treatments, focusing on personalization. Novartis utilizes CAR-T cell therapy, transforming the body's immune system into a personalized cancer-fighting force. Bristol Myers Squibb empowers the immune system with checkpoint inhibitors for full-scale attacks on cancer cells. Moderna leverages its mRNA technology to trigger an immune response, while Curis develops therapeutics using small molecule inhibitors and monoclonal antibodies to target cancer cell proliferation. These efforts are revolutionizing cancer treatment, creating a hopeful path towards a cancer-free future.

Full article here: https://medium.com/@lawsuithelpdesk/unraveling-the-mysteries-of-cancer-the-revolutionary-breakthroughs-you-need-to-know-now-2900462427e3

YouTube
LinkedIn
LinkedIn
Share